None of the patients initially reported as having an SfMB developed monoclonal gammopathy during their follow-up period. We recommend that cases reported as "suspicious" be managed separately in patients with and without a prior monoclonal gammopathy diagnosis, where the term "weak positive" may be more appropriate in patients with a known monoclonal gammopathy.
Building similarity graph...
Analyzing shared references across papers
Loading...
Dincer et al. (Thu,) studied this question.
synapsesocial.com/papers/69e71423cb99343efc98d92f — DOI: https://doi.org/10.1093/labmed/lmag013
Merve Dincer
Laboratoire de Biochimie
Özgür Aydın
Dokuz Eylül University
Volkan Karakuş
Antalya Eğitim ve Araştırma Hastanesi
Laboratory Medicine
Antalya IVF
Antalya Eğitim ve Araştırma Hastanesi
Building similarity graph...
Analyzing shared references across papers
Loading...
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: